Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.004 |